OpenAlex Citation Counts

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial
Huijie Bian, Zhaohui Zheng, Wei Ding, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 54

Showing 26-50 of 54 citing articles:

Bispecific Antibodies Provide Broad Neutralization of Emerging Beta-Coronaviruses by Targeting ACE2 and Viral Spikes
Minghui Li, Chaoyue Zhao, Jialu Shi, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1

Efficacy and Safety of SARS-CoV-2 Neutralizing Antibody JS016 in Hospitalized Chinese Patients with COVID-19: a Phase 2/3, Multicenter, Randomized, Open-Label, Controlled Trial
Run Dong, Li Jiang, Ting Yang, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 3
Open Access | Times Cited: 8

Lactylation: A Novel Post-Translational Modification with Clinical Implications in CNS Diseases
Junyan Liu, Fengyan Zhao, Yi Qu
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1175-1175
Open Access | Times Cited: 1

Elevated Levels of Soluble CD147 are Associated with Hyperinflammation and Disease Severity in COVID-19: A Proof-of-Concept Clinical Study
Rashidi Springall, Julieta González-Flores, Carlos García-Ávila, et al.
Archivum Immunologiae et Therapiae Experimentalis (2022) Vol. 70, Iss. 1
Open Access | Times Cited: 7

Pharmacological interventions to prevent Covid‐19 disease: A rapid review
Karen Cardwell, Éamon Ó Murchú, Paula Byrne, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 3
Open Access | Times Cited: 9

Repurposing Niclosamide as a Novel Anti-SARS-CoV-2 Drug by Restricting Entry Protein CD147
Zhe Yang, Qi Zhang, Xiaoqing Wu, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 2019-2019
Open Access | Times Cited: 3

Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
Fan Yang, Chenglong Liu, Pengyuan Li, et al.
Molecular Pharmacology (2023) Vol. 104, Iss. 6, pp. 239-254
Closed Access | Times Cited: 2

Update: Drug treatment options for coronavirus disease 2019 (COVID-19)
Yueming Shao, Jun Chen, Hongzhou Lu
BioScience Trends (2021) Vol. 15, Iss. 5, pp. 345-349
Open Access | Times Cited: 6

COVID-19: From Cough to Coffin
Patrick Chambers
OALib (2022) Vol. 09, Iss. 01, pp. 1-24
Open Access | Times Cited: 4

Significance of Immune Status of SARS-CoV-2 Infected Patients in Determining the Efficacy of Therapeutic Interventions
Ganesh Dattatraya Saratale, Han‐Seung Shin, Surendra K. Shinde, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 3, pp. 349-349
Open Access | Times Cited: 4

Human Cell Organelles in SARS-CoV-2 Infection: An Up-to-Date Overview
Anna Gorący, Jakub Rosik, Bartosz Szostak, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 1092-1092
Open Access | Times Cited: 4

From Cold to Killer: How SARS-CoV-2 Evolved without Hemagglutinin Esterase to Agglutinate and Then Clot Blood Cells
David Scheim
(2022)
Open Access | Times Cited: 4

Repurposing niclosamide as a novel anti-SARS-Cov-2 drug by restricting entry protein CD147
Zhe Yang, Qi Zhang, Xiaoqing Wu, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2

Exploring the Impact of Herbal Therapies on COVID-19 and Influenza: Investigating Novel Delivery Mechanisms for Emerging Interventions
Lucas Fornari Laurindo, Ledyane Taynara Marton, Giulia Minniti, et al.
Biologics (2023) Vol. 3, Iss. 3, pp. 158-186
Open Access | Times Cited: 2

The CD147 Epitope on SARS CoV2 and the Spike in Cancer, Autoimmunity and Organ Fibrosis
Patrick Chambers
(2023)
Open Access | Times Cited: 2

Impact of the COVID-19 Duration on Neglected Parasitic Diseases
Özlem Ulusan Bağcı
Turkish Journal of Parasitology (2021) Vol. 45, Iss. 4, pp. 317-325
Open Access | Times Cited: 5

Safety, Biodistribution, and Dosimetry Study of Meplazumab, a Potential COVID-19 Therapeutic Drug, with ¹³¹I-Labeling and SPECT Imaging
Jiajun Ye, Weidong Yang, Zhaojuan Xie, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 3, pp. 1750-1757
Closed Access | Times Cited: 1

Unique role of molecular imaging probes for viral infection
Song Liu, Teli Liu, Wei Tian, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 170, pp. 117470-117470
Open Access | Times Cited: 1

A Comparative and Comprehensive Review of Antibody Applications in the Treatment of Lung Disease
Yuefeng Wu, Hai Song
Life (2022) Vol. 12, Iss. 1, pp. 130-130
Open Access | Times Cited: 2

ACPA-CD147 axis in the NLRP3 inflammasome of RA macrophages
Kui Zhang, Zheng Yan, Zhaohui Zheng, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 8, pp. 957-959
Open Access | Times Cited: 2

Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations
Valentina Bonetto, Laura Pasetto, Ilaria Lisi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2

Current Therapeutic Strategies and Possible Effective Drug Delivery Strategies against COVID-19
Debabrata Ghosh Dastidar, Dipanjan Ghosh, Swarnasree Ghosh, et al.
Current Drug Delivery (2022) Vol. 20, Iss. 10, pp. 1441-1464
Closed Access | Times Cited: 2

Effect of COVID-19 vaccination on the immune status and autoantibody profile in women of reproductive age
Alina А. Dovgan, Yu. S. Drapkina, Н. В. Долгушина, et al.
Medical Immunology (Russia) (2022) Vol. 24, Iss. 5, pp. 979-992
Open Access | Times Cited: 2

Potential of Dietary Flavonoids in The Prevention and Therapy of COVID-19 : Focusing in Mast Cell - Calcium Ion Channel Axis
Aryo Tedjo
Indonesian Journal of Medical Chemistry and Bioinformatics (2023) Vol. 1, Iss. 2
Open Access

Previous Page - Page 2 - Next Page

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
cookielawinfo-checkbox-functional	1 year	The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
cookielawinfo-checkbox-others	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others".
cookielawinfo-checkbox-performance	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSID	session	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.

Requested Article:

Showing 26-50 of 54 citing articles:

Your Privacy